Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!

Range Low Price High Price Comment
30 days $6.10 $80.02 Wednesday, 8th May 2024 ARWR stock ended at $25.22. This is 0.88% more than the trading day before Tuesday, 7th May 2024. During the day the stock fluctuated 3.99% from a day low at $24.30 to a day high of $25.27.
90 days $71.43 $25.28
52 weeks $0.340 $25.28

Historical Arrowhead Research Corporation prices

Date Open High Low Close Volume
Jul 01, 2016 $5.29 $5.58 $5.29 $5.50 284 700
Jun 30, 2016 $5.39 $5.50 $5.28 $5.32 357 300
Jun 29, 2016 $5.37 $5.46 $5.25 $5.41 351 800
Jun 28, 2016 $5.11 $5.40 $5.11 $5.31 449 200
Jun 27, 2016 $5.42 $5.45 $5.08 $5.14 577 600
Jun 24, 2016 $5.58 $5.78 $5.28 $5.47 1 323 500
Jun 23, 2016 $5.73 $5.89 $5.67 $5.88 267 200
Jun 22, 2016 $5.65 $5.80 $5.52 $5.68 388 100
Jun 21, 2016 $5.91 $5.94 $5.56 $5.65 319 900
Jun 20, 2016 $5.82 $5.99 $5.76 $5.88 353 100
Jun 17, 2016 $5.94 $5.94 $5.71 $5.74 579 300
Jun 16, 2016 $5.93 $5.93 $5.93 $5.93 302 202
Jun 15, 2016 $5.81 $5.81 $5.81 $5.81 431 813
Jun 14, 2016 $5.71 $5.71 $5.71 $5.71 492 762
Jun 13, 2016 $5.87 $5.87 $5.87 $5.87 375 440
Jun 10, 2016 $5.85 $5.85 $5.85 $5.85 466 849
Jun 09, 2016 $5.99 $5.99 $5.99 $5.99 388 756
Jun 08, 2016 $6.08 $6.08 $6.08 $6.08 317 821
Jun 07, 2016 $6.15 $6.15 $6.15 $6.15 277 786
Jun 06, 2016 $6.24 $6.24 $6.24 $6.24 526 866
Jun 03, 2016 $6.12 $6.12 $6.12 $6.12 334 545
Jun 02, 2016 $6.18 $6.18 $6.18 $6.18 373 912
Jun 01, 2016 $6.03 $6.03 $6.03 $6.03 427 841
May 31, 2016 $6.13 $6.13 $6.13 $6.13 459 735
May 27, 2016 $5.89 $5.89 $5.89 $5.89 298 109
Click to get the best stock tips daily for free!

About Arrowhead Research Corporation

Arrowhead Research Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, which is in phase 2b and one phase 3 clinical trial to treat hypertriglyceridemia; ARO-ANG3 that is in P... ARWR Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT